April 16, 2026 Sweden
Biostock: Status update with Diamyd Medical
Diamyd Medical’s CEO Ulf Hannelius answers viewers' question on the strategic alternatives now being evaluated for the company's future.
Produced in collaboration with Biostock and moderated by Cecilia Hallström.
Read the article/watch video here
Information presented here are not press releases and may include excerpts from and links to externally published content. Diamyd Medical is not responsible for externally published content.